Antibody-drug conjugates: an evolving approach for melanoma treatment

Volume: 31, Issue: 1, Pages: 1 - 17
Published: Nov 6, 2020
Abstract
Melanoma continues to be an aggressive and deadly form of skin cancer while therapeutic options are continuously developing in an effort to provide long-term solutions for patients. Immunotherapeutic strategies incorporating antibody-drug conjugates (ADCs) have seen varied levels of success across tumor types and represent a promising approach for melanoma. This review will explore the successes of FDA-approved ADCs to date compared to the...
Paper Details
Title
Antibody-drug conjugates: an evolving approach for melanoma treatment
Published Date
Nov 6, 2020
Volume
31
Issue
1
Pages
1 - 17
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.